Human gene therapy trials are tightly controlled.

FORBES: Performance Drugs Outrun The Olympics

It will move the IL-12 drug and other cancer gene therapy approaches through human trials while Intrexon continues to work on basic science.

FORBES: The Next Big Move For The Smartest Biotech Investor